33
/it/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
August 1, 2025
10193602
975418
2

8 marzo 2024 anni - Wegovy Approved by The FDA

Descrizione:

The FDA expands the approval of semaglutide (Wegovy) to include heart disease, making it the first weight-loss drug to be approved for reducing the risk of cardiovascular events in adults who have cardiovascular disease and are either obese or overweight.

Aggiunto al nastro di tempo:

Data:

8 marzo 2024 anni
Adesso
~ 1 years and 3 months ago